Patents by Inventor E. Fink

E. Fink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12110601
    Abstract: A method for producing a cement material wherein 1) a first acid is reacted with a first cement precursor to form a second cement precursor, and 2) the second cement precursor is converted to a cement material. The first cement precursor includes one or more of Ca, Si, or Al, and the reaction with the first acid produces a second cement precursor that includes one or more of Ca, Si, or Al, and the conjugate base of the first acid. The second step can be performed by thermally converting the second cement precursor to a cement material by sintering or thermally decomposing the second cement precursor at a temperature in the range of 500 to 2000° C. The first step can be performed in the presence of water as a wet slurry. The concentration of the first acid can be greater than 20% by weight.
    Type: Grant
    Filed: August 24, 2022
    Date of Patent: October 8, 2024
    Assignee: California Institute of Technology
    Inventor: Cody E. Finke
  • Patent number: 12012374
    Abstract: The present invention is directed to compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: June 18, 2024
    Assignee: Bristol-Myers Squibb Company
    Inventors: Lalgudi S. Harikrishnan, Muthoni G. Kamau, Brian E. Fink
  • Publication number: 20240109899
    Abstract: The present invention is directed to compounds of formula (I) and (II), wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Application
    Filed: February 3, 2022
    Publication date: April 4, 2024
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: BRIAN E. FINK, EMILY CHARLOTTE CHERNEY, LIPING ZHANG, JULIAN C. LO, GRETCHEN M. SCHROEDER, TRAM N. HUYNH, DONNA D. WEI, VIJAY T. AHUJA, CLAUDE A. QUESNELLE
  • Patent number: 11945834
    Abstract: The present invention is directed to compounds of formulae (I) and (II) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: April 2, 2024
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Brian E. Fink, Zheming Ruan
  • Publication number: 20240009372
    Abstract: A portable negative pressure wound therapy system includes a dressing assembly for positioning over a wound to apply a negative pressure to the wound and a canister assembly. The canister assembly includes a control unit having a vacuum source and a controller and a collection canister in communication with the dressing assembly operable to receive fluid from the wound. The collection canister has a filter assembly having a filter and a passageway between the filter and a wall of the collection canister. The collection canister also includes a canister interface having a suction port, an inlet port, and a channel. The vacuum source draws air through the suction port from the channel which draws air from the passageway connected to the channel, the air in the passageway is drawn from the collection canister through the filter, and the air in the collection canister is drawn through the inlet port.
    Type: Application
    Filed: June 30, 2023
    Publication date: January 11, 2024
    Inventors: Richard M. Braga, David E. Fink, David Heagle, Arnaz S. Malhi, David R. Swisher, Scott Wudyka
  • Publication number: 20230295087
    Abstract: The present invention is directed to compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Application
    Filed: May 8, 2020
    Publication date: September 21, 2023
    Inventors: Lalgudi S. Harikrishnan, Brian E. Fink, Patrice Gill, Lan-Ying Qin, Muthoni G. Kamau, Tram N. Huynh, Ashok Vinayak Purandare, Honghe Wan, Daniel O’Malley
  • Patent number: 11739431
    Abstract: A method for producing a cement material wherein 1) a first acid is reacted with a first cement precursor to form a second cement precursor, and 2) the second cement precursor is converted to a cement material. The first cement precursor includes one or more of Ca, Si, or Al, and the reaction with the first acid produces a second cement precursor that includes one or more of Ca, Si, or Al, and the conjugate base of the first acid. The second step can be performed by thermally converting the second cement precursor to a cement material by sintering or thermally decomposing the second cement precursor at a temperature in the range of 500 to 2000° C. The first step can be performed in the presence of water as a wet slurry. The concentration of the first acid can be greater than 20% by weight.
    Type: Grant
    Filed: August 24, 2022
    Date of Patent: August 29, 2023
    Assignee: California Institute of Technology
    Inventor: Cody E. Finke
  • Patent number: 11718558
    Abstract: Aspects of the invention include a method of producing a cement material comprising step of: first reacting a calcium-bearing starting material with a first acid to produce an aqueous first calcium salt; second reacting the aqueous first calcium salt with a second acid to produce a solid second calcium salt; wherein the second acid is different from the first acid and the second calcium salt is different from the first calcium salt; and thermally treating the second calcium salt to produce a first cement material. Preferably, but not necessarily, during the second reacting step, reaction between the first calcium salt and the second acid regenerates the first acid.
    Type: Grant
    Filed: August 24, 2022
    Date of Patent: August 8, 2023
    Assignees: California Institute of Technology, Brimstone Energy Inc.
    Inventors: Cody E. Finke, Hugo F. Leandri
  • Publication number: 20230242478
    Abstract: The present invention is directed to compounds of the formula [INSERT CHEMICAL STRUCTURE HERE}] wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Application
    Filed: May 7, 2020
    Publication date: August 3, 2023
    Inventors: Lalgudi S. Harikrishnan, Muthoni G. Kamau, Brian E. Fink
  • Patent number: 11693861
    Abstract: A system and process for generalizing an evolutionary process applied to a particular domain involving different problems includes a researcher module for generating a configuration specification applicable to a particular problem. An evolution module parses the configuration specification into a representative tree structure, assembles policies for each node in the tree structure, and generates candidate genomes using the policies for each node in the tree structure. The policies may be applied to new data or data from prior runs to generate candidate genomes. The evolution module translates internal representations of the generated candidate genomes into known representations of the candidate genome for evaluation in accordance with the particular domain parameters by a candidate evaluation module.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: July 4, 2023
    Assignee: Cognizant Technology Solutions U.S. Corportion
    Inventor: Daniel E. Fink
  • Patent number: 11660311
    Abstract: The present invention is directed to compounds of the formula (I), wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Grant
    Filed: October 9, 2018
    Date of Patent: May 30, 2023
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Brian E. Fink, Dharmpal S. Dodd, Yufen Zhao, Lan-Ying Qin, Zheming Ruan, Lalgudi S. Harikrishnan, Muthoni G. Kamau
  • Patent number: 11477166
    Abstract: Described herein is a process which facilitates segmented security between domain-specific data sets being evaluated as part of a candidate evaluation service and third-party evolution services, wherein the data sets are not transmitted to the evolution service which is evolving candidates for evaluation. This enables customers with secure data sets to use candidate evolution services securely by obtaining a population of potentially optimal candidate models to evaluate and then optimizing on those data sets in their own secure fashion.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: October 18, 2022
    Assignee: Cognizant Technology Solutions U.S. Corporation
    Inventors: Daniel E. Fink, Olivier Francon
  • Patent number: 11462816
    Abstract: Disclosed herein is a combination faceplate antenna holder for an electric utility meter.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: October 4, 2022
    Assignee: Aclara Technologies LLC
    Inventors: Steven Donkle, Lewis E. Fink, III, Michael Smith, Wayne Therrien
  • Publication number: 20220306630
    Abstract: The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Application
    Filed: August 5, 2020
    Publication date: September 29, 2022
    Inventors: Lalgudi S. Harikrishnan, Peter Kinam Park, Zheming Ruan, Donna D. Wei, Daniel O'Malley, Honghe Wan, Ashok Vinayak Purandare, Brian E. Fink
  • Patent number: 11427610
    Abstract: The present invention is directed to compounds of the formula wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: August 30, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: Brian E. Fink, Yufen Zhao, Libing Chen, Audris Huang
  • Patent number: 11339185
    Abstract: The present invention is directed to compounds of the formulae I, II and III as shown below wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: May 24, 2022
    Assignee: Bristol-Myers Squibb Company
    Inventors: Brian E. Fink, Dharmpal S. Dodd, Steven J. Walker, Libing Chen, Yufen Zhao, Zheming Ruan, Lan-Ying Qin, Peter Kinam Park, Muthoni G. Kamau, Lalgudi S. Harikrishnan
  • Publication number: 20220117995
    Abstract: The present invention is directed to compounds of the formula (I), wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
    Type: Application
    Filed: October 9, 2018
    Publication date: April 21, 2022
    Inventors: Brian E. FINK, Dharmpal S. Dodd, Yufen Zhao, Lan-Ying Qin, Zheming Ruan, Lalgudi S. Harikrishnan, Muthoni G. Kamau
  • Publication number: 20220109654
    Abstract: Systems and processes for facilitating the sharing of models trained on a data set confined within a given firewall, i.e., a hidden data set, along with the model's performance metrics are described. The trained models may be used in further processes to improve the trained models to solve a predetermined problem or make a prediction.
    Type: Application
    Filed: October 7, 2020
    Publication date: April 7, 2022
    Applicant: Cognizant Technology Solutions U.S. Corporation
    Inventors: Daniel E. Fink, Jason Liang, Risto Miikkulainen
  • Patent number: 11180860
    Abstract: In an aspect, provided herein are methods for producing sulfuric acid and hydrogen gas, the methods comprising steps of: providing sulfur dioxide formed by thermal conversion of a sulfur-containing species; electrochemically oxidizing said sulfur dioxide to sulfuric acid in the presence of water; and electrochemically forming hydrogen gas via a reduction reaction. In some embodiments, the methods comprise a step of thermally converting said sulfur-containing species to said sulfur dioxide. Systems configured to perform these methods are also disclosed herein. Also provided herein are methods and systems for producing sulfuric acid and hydrogen gas by electrochemically forming the sulfuric acid and the hydrogen gas in a mixture comprising a sulfur material, a supporting acid, and water. Also provided herein are methods and systems for producing a cement material.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: November 23, 2021
    Assignee: California Institute of Technology
    Inventor: Cody E. Finke
  • Publication number: 20210334285
    Abstract: A system and process for generalizing an evolutionary process applied to a particular domain involving different problems includes a researcher module for generating a configuration specification applicable to a particular problem. An evolution module parses the configuration specification into a representative tree structure, assembles policies for each node in the tree structure, and generates candidate genomes using the policies for each node in the tree structure. The policies may be applied to new data or data from prior runs to generate candidate genomes. The evolution module translates internal representations of the generated candidate genomes into known representations of the candidate genome for evaluation in accordance with the particular domain parameters by a candidate evaluation module.
    Type: Application
    Filed: July 6, 2021
    Publication date: October 28, 2021
    Applicant: Cognizant Technology Solutions U.S. Corporation
    Inventor: Daniel E. Fink